• Home
  • About Us
    • Our Mission
    • About Us
  • Solutions
    • Digital Procurement Platform
    • NCD Market Pathway
  • News
  • Contact us
    • Contact us
    • Book a demo
  • fr_FR
Go to the Platform
How WHO Recommendations for NCDs Impact Global Health

How WHO Recommendations for NCDs Impact Global Health

by Agathe Masson | Mar 31, 2025 | Access to Care, NCD Policy, News

Noncommunicable diseases (NCDs) are among the leading causes of death and disability worldwide, posing an immense burden on healthcare systems, economies, and individuals—especially in countries with a low Human Development Index (HDI). Recognising the urgency of...
Brand-Name and Generic Medicines: 2 Sides of the Same Coin

Brand-Name and Generic Medicines: 2 Sides of the Same Coin

by Agathe Masson | Dec 9, 2024 | Access to Care, NCD Policy, News

Access to essential treatments is a cornerstone of effective healthcare systems. Both brand-name medicines and generics play vital roles in ensuring that patients receive the care they need. While brand-name medicines are often associated with innovation and...
Regional Leadership: Driving Lasting Change in NCD Management

Regional Leadership: Driving Lasting Change in NCD Management

by Agathe Masson | Nov 19, 2024 | Healthcare Systems, NCD Policy, News

“Localisation.” It’s a term we’ve heard frequently in recent years, but not without its critics—and perhaps rightly so. Many argue that “localisation” doesn’t fully capture the essence of legitimising communities to lead their own health solutions, often implying a...
Integrating NCDs into National Health Plans: Smarter Financing and Buying Strategies

Integrating NCDs into National Health Plans: Smarter Financing and Buying Strategies

by Agathe Masson | Sep 9, 2024 | NCD Financing, NCD Policy, News

Over the past two decades, noncommunicable diseases (NCDs) and mental health have evolved from niche concerns in global health to central pillars of the sustainable development agenda. Since the 2011 High-level Meeting on the Prevention and Control of NCDs,...
Combating the Scourge of Substandard Medicines in Low and Middle-Income Countries

Combating the Scourge of Substandard Medicines in Low and Middle-Income Countries

by Callie Weber | Jan 8, 2024 | Access to Care, NCD Policy, News

Counterfeit and substandard medicine trafficking is one of the world’s fastest-growing and highest-value criminal enterprises. Analysts estimate the global counterfeit market to be worth between US$200 and $432 billion. Since the issue first came to light in a 2003...

Your partner in providing simple access to quality-assured NCD supplies, offering flexible digital solutions to meet your unique supply chain needs and improve the lives of those living with NCDs.

ORGANISATION

Our Mission

About us

News

Contact us

Privacy Policy

SOLUTIONS

Digital Procurement Platform

NCD Market Pathway

Book A Demo

FAQ

An initiative by

IDA Foundation - Solvoz

Follow us

  • Follow